{
    "Rank": 933,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT02743052",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "SMC 2016-02-104"
                },
                "Organization": {
                    "OrgFullName": "Samsung Medical Center",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Anticoagulation in Cancer Related Stroke",
                "OfficialTitle": "Optimal Anticoagulation Strategy In Stroke Related to CANCER (OASIS-CANCER Study)",
                "Acronym": "OASIS-CANCER"
            },
            "StatusModule": {
                "StatusVerifiedDate": "March 2016",
                "OverallStatus": "Unknown status",
                "LastKnownStatus": "Recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "October 2009"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "December 2018",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "December 2018",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "March 10, 2016",
                "StudyFirstSubmitQCDate": "April 18, 2016",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "April 19, 2016",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "April 18, 2016",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "April 19, 2016",
                    "LastUpdatePostDateType": "Estimate"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Samsung Medical Center",
                    "LeadSponsorClass": "OTHER"
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "Purpose: Cancer associated intravascular coagulopathy is the primary mechanism of cancer-related stroke, particularly in those without conventional stroke etiologies. Randomized clinical trials have investigated efficacy of vitamin K-dependent oral anticoagulant (warfarin), low-molecular-weight heparin (LMWH) and non-vitamin K-dependent oral anticoagulant (NOAC) for the prevention of systematic venous thromboembolism. However, relatively little is known about the biological changes underlying intravascular coagulopathy and mechanisms of anticoagulation therapy in patients with cancer-related stroke. The aim of this study is to evaluate to determine the biological markers for intravascular coagulopathy causing stroke and for monitoring the effects of anticoagulation therapy, in patients with active cancer and stroke."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Cancer",
                        "Stroke"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "PatientRegistry": "No",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Cohort"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "400",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Drug",
                            "InterventionName": "Anticoagulation treatment.",
                            "InterventionDescription": "Details of anticoagulation treatment information will be gathered including low molecular-weight heparin (enoxaparin 1 mg/kg) vs. NOAC (rivaroxaban 15 or 20 mg), vs. warfarin (target INR2.0-3.0) or no use of anticoagulation per physicians' decision and patients' conditions."
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Recurrent stroke or systemic embolism",
                            "PrimaryOutcomeDescription": "Recurrent stroke (development of neurologic deterioration or a new symptom/sign and relevant new cerebral lesions documented by a neuroimaging study) or systemic embolism (objectively documented, symptomatic, recurrent deep-vein thrombosis, pulmonary embolism, or both ).",
                            "PrimaryOutcomeTimeFrame": "up to 6 months"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "90-days modified Rankin Scale score",
                            "SecondaryOutcomeTimeFrame": "examined at 90 days after stroke symptom onset in each patients"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Effect of anticoagulation treatment",
                            "SecondaryOutcomeDescription": "Effect of anticoagulation will be measured with D-dimer level during admission",
                            "SecondaryOutcomeTimeFrame": "up to 14 days"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Symptomatic hemorrhagic transformation",
                            "SecondaryOutcomeDescription": "Symptomatic hemorrhagic transformation (newly developed cerebral hemorrhages that were temporally related to neurologic deterioration) or major bleeding up to 6 months (as defined by the International Society on Thrombosis and Haemostasis, J Thromb Haemost 2005;3:692-4)",
                            "SecondaryOutcomeTimeFrame": "up to 6 months"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nAge 20 years and older\nAcute ischemic stroke presented within 7 days of symptom onset\nCancer related stroke: active cancer (diagnosis of cancer within 6 months of stroke onset, any treatment for cancer within the previous 6 months, or recurrent or metastatic cancer) and ischemic stroke which could not be explained by conventional stroke mechanisms including large artery atherosclerosis, cardioembolism, lacunar infarction, or other etiologies (e.g., dissection)\nSigned informed consent or appropriate signed deferral of consent where approved\n\nExclusion Criteria:\n\nPrimary intracranial malignancy\nIncomplete workup for stroke etiology (either vascular or cardiologic studies)\nAny signs of infectious or immunological diseases which may influence plasma D-dimer levels\nPatients with stroke suspected to be caused by the tumor itself (i.e., tumor emboli) or cancer treatment (i.e., chemotherapy-induced stroke)",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "MinimumAge": "20 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Acute ischemic stroke patients with active cancer",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "CentralContactList": {
                    "CentralContact": [
                        {
                            "CentralContactName": "Jong-Won Chung, MD, MSc",
                            "CentralContactRole": "Contact",
                            "CentralContactPhone": "82-2-3410-3599",
                            "CentralContactEMail": "neurocjw@gmail.com"
                        }
                    ]
                },
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Oh Young Bang, MD, PhD",
                            "OverallOfficialAffiliation": "Samsung Medical Center",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Samsung Medical Center, Sungkyunkwan University School of Medicine",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Seoul",
                            "LocationZip": "135710",
                            "LocationCountry": "Korea, Republic of",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Jong-Won Chung, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactPhone": "82234101895",
                                        "LocationContactEMail": "neurocjw@gmail.com"
                                    },
                                    {
                                        "LocationContactName": "Oh Young Bang, MD",
                                        "LocationContactRole": "Principal Investigator"
                                    },
                                    {
                                        "LocationContactName": "Kwang Ho Lee, MD",
                                        "LocationContactRole": "Sub-Investigator"
                                    },
                                    {
                                        "LocationContactName": "Chin-Sang Chung, MD",
                                        "LocationContactRole": "Sub-Investigator"
                                    },
                                    {
                                        "LocationContactName": "Jong-Won Chung, MD",
                                        "LocationContactRole": "Sub-Investigator"
                                    }
                                ]
                            }
                        }
                    ]
                }
            },
            "IPDSharingStatementModule": {
                "IPDSharing": "No"
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000020521",
                            "ConditionMeshTerm": "Stroke"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000002561",
                            "ConditionAncestorTerm": "Cerebrovascular Disorders"
                        },
                        {
                            "ConditionAncestorId": "D000001927",
                            "ConditionAncestorTerm": "Brain Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000002493",
                            "ConditionAncestorTerm": "Central Nervous System Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000009422",
                            "ConditionAncestorTerm": "Nervous System Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000014652",
                            "ConditionAncestorTerm": "Vascular Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000002318",
                            "ConditionAncestorTerm": "Cardiovascular Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M21996",
                            "ConditionBrowseLeafName": "Stroke",
                            "ConditionBrowseLeafAsFound": "Stroke",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M5500",
                            "ConditionBrowseLeafName": "Cerebrovascular Disorders",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M4894",
                            "ConditionBrowseLeafName": "Brain Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M5432",
                            "ConditionBrowseLeafName": "Central Nervous System Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17090",
                            "ConditionBrowseLeafName": "Vascular Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC10",
                            "ConditionBrowseBranchName": "Nervous System Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC14",
                            "ConditionBrowseBranchName": "Heart and Blood Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            },
            "InterventionBrowseModule": {
                "InterventionBrowseLeafList": {
                    "InterventionBrowseLeaf": [
                        {
                            "InterventionBrowseLeafId": "M19842",
                            "InterventionBrowseLeafName": "Enoxaparin",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M19843",
                            "InterventionBrowseLeafName": "Dalteparin",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M1943",
                            "InterventionBrowseLeafName": "Tinzaparin",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M9271",
                            "InterventionBrowseLeafName": "Heparin, Low-Molecular-Weight",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M463",
                            "InterventionBrowseLeafName": "Rivaroxaban",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M9269",
                            "InterventionBrowseLeafName": "Heparin",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M17292",
                            "InterventionBrowseLeafName": "Warfarin",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M45780",
                            "InterventionBrowseLeafName": "Calcium heparin",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M136959",
                            "InterventionBrowseLeafName": "Enoxaparin sodium",
                            "InterventionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "InterventionBrowseBranchList": {
                    "InterventionBrowseBranch": [
                        {
                            "InterventionBrowseBranchAbbrev": "FiAg",
                            "InterventionBrowseBranchName": "Fibrinolytic Agents"
                        },
                        {
                            "InterventionBrowseBranchAbbrev": "AnCoag",
                            "InterventionBrowseBranchName": "Anticoagulants"
                        },
                        {
                            "InterventionBrowseBranchAbbrev": "All",
                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                        }
                    ]
                }
            }
        }
    }
}